financetom
Business
financetom
/
Business
/
KKR, GIP lead $25 billion regional infrastructure tie-up, US says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
KKR, GIP lead $25 billion regional infrastructure tie-up, US says
Jun 5, 2024 11:51 PM

SINGAPORE, June 6 (Reuters) - KKR, Global

Infrastructure Partners (GIP) and the Indo-Pacific Partnership

for Prosperity have formed a coalition to invest $25 billion in

infrastructure in the Indo-Pacific region, U.S. Commerce

Secretary Gina Raimondo said on Thursday.

Raimondo, speaking in Singapore, said investment would

include green data centres in Indonesia, renewable energy in the

Philippines and smart metres and hybrid renewables in India.

"Coalition members (of the Indo-Pacific Economic Framework)

will help facilitate the identification, promotion, and

development of successful infrastructure projects across the

region," the three organisations said in a joint statement.

The coalition will initially focus on scaled infrastructure

investment across the energy, transportation, water and waste,

and digital sectors, they said in the statement.

Private equity firms KKR and GIP will co-chair the

initiative, while global investors including BlackRock ( BLK ),

GIC, Rockefeller Foundation and Temasek will

be a part of the coalition, the statement showed.

Raimondo said over $23 billion of investment

opportunities had been identified by the Indo-Pacific Economic

Framework (IPEF).

Investment opportunities numbering 69 "sustainable

infrastructure" projects were identified at an IPEF Investor

Forum, Singapore's trade ministry, which organised the forum,

said on Thursday.

"Of these, 20 investment-ready projects worth about $6

billion were presented to investors. Remaining projects worth

about $17 billion were also identified as potential investment

opportunities," the ministry said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Corcept Therapeutics Insider Sold Shares Worth $1,581,687, According to a Recent SEC Filing
Corcept Therapeutics Insider Sold Shares Worth $1,581,687, According to a Recent SEC Filing
Jun 5, 2025
03:45 AM EDT, 06/05/2025 (MT Newswires) -- Sean Maduck, President, Corcept Endocrinology, on June 02, 2025, sold 20,000 shares in Corcept Therapeutics ( CORT ) for $1,581,687. Following the Form 4 filing with the SEC, Maduck has control over a total of 117,398 common shares of the company, with 17,705 shares held directly and 99,693 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1088856/000095017025081933/xslF345X05/ownership.xml...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Procter & Gamble to cut 7,000 jobs over two years
Procter & Gamble to cut 7,000 jobs over two years
Jun 5, 2025
June 5 (Reuters) - Procter & Gamble ( PG ) said on Thursday it would cut 7,000 jobs, or about 15% of its non-manufacturing roles, globally over the next two years as part of its non-core restructuring program. P&G also plans to exit of some categories, brands and product forms in individual markets, executives said at a Deutsche Bank conference...
Corcept Therapeutics Insider Sold Shares Worth $3,314,310, According to a Recent SEC Filing
Corcept Therapeutics Insider Sold Shares Worth $3,314,310, According to a Recent SEC Filing
Jun 5, 2025
03:44 AM EDT, 06/05/2025 (MT Newswires) -- Joseph K Belanoff, Director, Chief Executive Officer, on June 02, 2025, sold 40,000 shares in Corcept Therapeutics ( CORT ) for $3,314,310. Following the Form 4 filing with the SEC, Belanoff has control over a total of 2,901,985 common shares of the company, with 2,901,985 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1088856/000095017025081939/xslF345X05/ownership.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved